the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Atezolizumab Immunotherapy in Patients With Advanced NSCLC
Official Title Phase II Trial of Induction Immunotherapy With Atezolizumab for Patients With Unresectable Stage IIIA and IIIB NSCLC Eligible for Chemoradiotherapy With Curative Intent.
Principal Investigator Patel, Jyoti
Brief Summary Phase II trial of induction immunotherapy with atezolizumab for patients with unresectable stage IIIA and IIIB NSCLC eligible for chemoradiotherapy with curative intent.
Gender All
Ages 18 Years
Enrollment 63
Accepts Healthy Volunteers No
Lead Sponsor Alliance Foundation Trials, LLC.Other
Collaborator
Study Design
Study Phase Phase 2
Study Type Interventional
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Carcinoma, Non-Small-Cell Lung
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI